NAVIGATING THE TRANSITION FROM IVDD TO IVDR
Tracks
SEVERO OCHOA ROOM
| Wednesday, October 8, 2025 |
| 12:15 - 13:00 |
| SEVERO OCHOA ROOM |
Overview
Sponsor: Asphalion
Details
This session provides an overview of the European Union's In Vitro Diagnostic Regulation (IVDR), its impact on the IVDD industry, and the regulatory path defined by the new regulation.
We will be able to detail the critical differences between the IVDD and IVDR, highlight the challenges associated with the transition, and explain the specific transition periods and conditions outlined by the regulation.
We will discuss the necessary steps manufacturers must take to comply with the Regulation (2024/1860), including quality management, technical documentation, and post-market surveillance.
The session will feature a Notified Body, a manufacturer, and a consultant, who will give us diverse perspectives on their roles and share valuable experiences on the transition to the IVDR.
Details
ASPHALION .
ASPHALION
Sponsor
Dr Francisco Rodríguez
Medical Device Manager
Asphalion, Spain
Moderator
Dr Walter Sanseverino
CEO
Sequentia Biotech SL, Spain
Speaker
Ms María Teresa Gómez Manzano
Medical Devices Manager Spain
SGS
Speaker
Ms Talyta Carteano
Director Medtech Unit
Asphalion, Spain
Speaker
Ms Josefa Güiles
Medtech Associate Director
Asphalion
Speaker